Results for "rare diseases."
Conditions Encyclopedia Entry 1781386767
Mitochondrial myopathies are a group of rare genetic disorders caused by mutations in the mitochondrial DNA, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1780260562
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MMs can vary widely depending on the specific disorder and the individual affected. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. In some cases, the disorder can be caused by a new mutation that occurs spontaneously during fertilization or early embryonic development. Mitochondrial myopathies can be diagnosed through a combination of clinical evaluation, laboratory tests, and genetic analysis. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to recognize the importance of mitochondrial function in cellular energy production. In the 1980s, the discovery of mitochondrial DNA and its role in energy production led to a greater understanding of the genetic basis of these disorders. Since then, advances in genetic testing and molecular biology have enabled researchers to identify the specific genetic mutations responsible for various forms of mitochondrial myopathies. ## Key Information There are over 150 known forms of mitochondrial myopathies, each with its own unique set of symptoms and characteristics. Some of the most common forms of MMs include: * **Kearns-Sayre Syndrome** (KSS): a rare disorder characterized by progressive external ophthalmoplegia, pigmentary retinopathy, and cardiac conduction abnormalities. * **Myoclonic Epilepsy with Ragged-Red Fibers** (MERRF): a disorder characterized by myoclonic seizures, ataxia, and ragged-red fibers in muscle biopsies. * **Neuropathy, Ataxia, and Retinitis Pigmentosa** (NARP): a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. ## Significance Mitochondrial myopathies are a significant public health concern due to their rarity and the severity of their symptoms. These disorders can have a profound impact on an individual's quality of life, causing muscle weakness, fatigue, and other systemic symptoms. In some cases, MMs can be life-threatening, particularly if they affect the heart or other critical organs. Research into mitochondrial myopathies has led to a greater understanding of the importance of mitochondrial function in human health and disease. This knowledge has also led to the development of new treatments and therapies for these disorders, including gene therapy and other innovative approaches. INFOBOX: - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first descriptions) - Location: Global - Known For: Rare genetic disorders affecting mitochondrial function TAGS: Mitochondrial myopathies, genetic disorders, mitochondrial DNA, Kearns-Sayre Syndrome, MERRF, NARP, gene therapy, rare diseases.
Health & MedicineConditions Encyclopedia Entry 1780707066
** **Mitochondrial Myopathies** are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. **CONTENT:** ### **Overview** Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA, which affects the energy production within cells. These conditions are characterized by progressive muscle weakness, fatigue, and other systemic symptoms. Mitochondrial myopathies can affect individuals of all ages, from infancy to adulthood, and are often inherited in an autosomal dominant or maternal pattern. The symptoms and severity of the condition vary widely among individuals, making diagnosis and treatment challenging. Mitochondrial myopathies are a subset of mitochondrial disorders, which are estimated to affect approximately 1 in 5,000 individuals worldwide. The conditions are often associated with other systemic symptoms, including gastrointestinal, neurological, and cardiac problems. In some cases, mitochondrial myopathies can be life-threatening, particularly if left untreated or if the condition progresses rapidly. ### **History/Background** The first reported case of mitochondrial myopathy dates back to 1962, when a British physician, **John Morgan Hughes**, described a patient with a rare condition characterized by muscle weakness and fatigue. However, it wasn't until the 1980s that the genetic basis of mitochondrial myopathies was identified. The discovery of mutations in the mitochondrial DNA revolutionized the understanding of these conditions and paved the way for genetic testing and diagnosis. ### **Key Information** Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which affects the energy production within cells. The most common mutations associated with these conditions include: * **MELAS syndrome** (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) * **MERRF syndrome** (Myoclonus Epilepsy with Ragged-Red Fibers) * **KSS syndrome** (Kearns-Sayre syndrome) * **NARP syndrome** (Neuropathy, Ataxia, and Retinitis Pigmentosa) Symptoms of mitochondrial myopathies can vary widely among individuals and may include: * **Muscle weakness** and fatigue * **Gastrointestinal problems**, such as diarrhea and abdominal pain * **Neurological symptoms**, including seizures and ataxia * **Cardiac problems**, including arrhythmias and cardiomyopathy * **Visual disturbances**, including blurred vision and loss of vision ### **Significance** Mitochondrial myopathies are a significant public health concern due to their rarity and the challenges associated with diagnosis and treatment. These conditions often require a multidisciplinary approach, involving geneticists, neurologists, cardiologists, and other specialists. Early diagnosis and treatment can significantly improve the quality of life for individuals with mitochondrial myopathies, but more research is needed to understand the underlying mechanisms of these conditions and to develop effective treatments. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1962 (first reported case) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria, leading to muscle weakness and systemic symptoms **TAGS:** Mitochondrial disorders, genetic disorders, muscle weakness, fatigue, gastrointestinal problems, neurological symptoms, cardiac problems, visual disturbances, rare diseases.
Health & MedicineConditions Encyclopedia Entry 1780472525
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. As a result, the mitochondria are unable to produce energy efficiently, leading to a range of symptoms and complications. Mitochondrial Myopathies can affect anyone, but they are more common in women, as they can pass the mutated mitochondrial DNA to their offspring. Mitochondrial Myopathies are characterized by a range of symptoms, including muscle weakness, fatigue, and exercise intolerance. Some people may experience muscle pain, cramping, or spasms, while others may experience vision problems, hearing loss, or cognitive impairment. In severe cases, Mitochondrial Myopathies can lead to life-threatening complications, such as heart failure or respiratory failure. ## History/Background The first reported case of Mitochondrial Myopathy was in 1962, when a British doctor, Brian Shyng, described a patient with a rare disorder that affected the muscles. However, it wasn't until the 1980s that the genetic basis of Mitochondrial Myopathies was discovered. In 1988, a team of scientists led by Douglas Wallace identified the first mitochondrial DNA mutation associated with a Mitochondrial Myopathy. Since then, numerous other mutations have been identified, and the condition has been recognized as a distinct group of disorders. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which are inherited from one's mother. There are over 200 known mitochondrial DNA mutations associated with Mitochondrial Myopathies, each with its own unique set of symptoms and characteristics. Some of the most common mutations include: - **MELAS** (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes): a severe form of Mitochondrial Myopathy that affects the brain, muscles, and other organs. - **MERRF** (Myoclonus Epilepsy with Ragged-Red Fibers): a form of Mitochondrial Myopathy that affects the muscles, brain, and other organs. - **KSS** (Kearns-Sayre Syndrome): a rare form of Mitochondrial Myopathy that affects the muscles, heart, and other organs. ## Significance Mitochondrial Myopathies are a significant public health concern, as they can affect anyone, regardless of age or background. While they are rare, they can have a profound impact on the lives of those affected, as well as their families. Research into Mitochondrial Myopathies has led to a greater understanding of the role of mitochondria in human health and disease, and has paved the way for the development of new treatments and therapies. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1962 (first reported case) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria TAGS: Mitochondrial Myopathies, genetic disorders, mitochondrial DNA, energy production, muscle weakness, fatigue, exercise intolerance, rare diseases.
Health & MedicineConditions Encyclopedia Entry 1781495825
** **Mitochondrial Myopathies** are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the function of the mitochondria. These organelles are responsible for generating energy for the cell through the process of oxidative phosphorylation. Mitochondrial myopathies can affect various systems in the body, including the nervous system, muscles, and other organs. The symptoms and severity of the disorder vary widely among individuals, and the condition can be inherited in an autosomal dominant, autosomal recessive, or matrilineal pattern. Mitochondrial myopathies are often characterized by muscle weakness, particularly in the muscles of the face, arms, and legs. Other common symptoms include fatigue, exercise intolerance, and muscle pain. Some individuals may also experience neurological symptoms, such as seizures, ataxia, and cognitive impairment. In severe cases, mitochondrial myopathies can lead to life-threatening complications, including respiratory failure, cardiac arrest, and multi-organ failure. ## History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with a rare disorder characterized by muscle weakness, exercise intolerance, and a unique pattern of mitochondrial DNA mutations. Since then, numerous studies have shed light on the genetic and molecular mechanisms underlying these disorders. In 1988, the first nuclear DNA mutation associated with mitochondrial myopathy was identified, marking a significant breakthrough in the field. Today, over 150 different mutations have been linked to mitochondrial myopathies, and researchers continue to explore the complex relationships between mitochondrial function, energy metabolism, and disease. ## Key Information Mitochondrial myopathies can be caused by mutations in either the mitochondrial DNA or nuclear DNA. The most common mtDNA mutations include: * **MELAS syndrome** (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes): a severe disorder characterized by muscle weakness, seizures, and stroke-like episodes. * **MERRF syndrome** (Myoclonus Epilepsy with Ragged-Red Fibers): a disorder marked by muscle weakness, seizures, and myoclonus (involuntary muscle contractions). * **KSS syndrome** (Kearns-Sayre Syndrome): a rare disorder characterized by muscle weakness, heart block, and pigmentary retinopathy. Nuclear DNA mutations associated with mitochondrial myopathies include: * **POLG mutations**: mutations in the polymerase gamma gene, which codes for an enzyme essential for mitochondrial DNA replication. * **TWNK mutations**: mutations in the twinkle gene, which codes for an enzyme involved in mitochondrial DNA replication and repair. ## Significance Mitochondrial myopathies are a significant public health concern due to their rarity and severity. According to the National Institutes of Health, mitochondrial myopathies affect approximately 1 in 5,000 individuals worldwide. While there is no cure for these disorders, researchers are actively exploring new treatments, including gene therapy, stem cell transplantation, and pharmacological interventions aimed at improving mitochondrial function. Understanding the genetic and molecular mechanisms underlying mitochondrial myopathies has also shed light on the importance of mitochondrial function in human health and disease. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first reported cases) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting mitochondrial function and leading to muscle weakness, fatigue, and other systemic symptoms. TAGS: Mitochondrial myopathies, genetic disorders, mitochondrial DNA, nuclear DNA, muscle weakness, fatigue, exercise intolerance, neurological symptoms, rare diseases.
Health & MedicineConditions Encyclopedia Entry 1781237405
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by the accumulation of mutations in the mitochondrial DNA, leading to impaired energy production and subsequent cellular damage. Mitochondrial Myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms and severity of MM can vary widely among individuals, and the disorders are often inherited in an autosomal dominant or maternal pattern. Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. These mutations can lead to impaired energy production, resulting in cellular damage and tissue dysfunction. The most common symptoms of MM include muscle weakness, fatigue, and exercise intolerance. Other symptoms may include muscle pain, weakness, and wasting, as well as neurological problems such as seizures, vision loss, and hearing loss. ### History/Background Mitochondrial Myopathies were first described in the 1980s, when scientists discovered that certain individuals with muscle weakness and fatigue had abnormal mitochondria. Since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying MM. In 1988, the first mitochondrial DNA mutation was identified as the cause of a mitochondrial myopathy. Since then, over 200 mitochondrial DNA mutations have been identified as causing MM. ### Key Information Mitochondrial Myopathies are a group of disorders that can be caused by a variety of mitochondrial DNA mutations. The most common mutations include those in the MT-ATP6, MT-ATP8, and MT-CO1 genes. These mutations can lead to impaired energy production, resulting in cellular damage and tissue dysfunction. The symptoms and severity of MM can vary widely among individuals, and the disorders are often inherited in an autosomal dominant or maternal pattern. Mitochondrial Myopathies can be diagnosed through a combination of clinical evaluation, genetic testing, and muscle biopsy. Genetic testing can identify the specific mitochondrial DNA mutation causing the disorder, while muscle biopsy can provide information on the extent of muscle damage. Treatment options for MM are limited, and management typically focuses on symptom relief and improving quality of life. ### Significance Mitochondrial Myopathies are a group of rare genetic disorders that can have a significant impact on an individual's quality of life. The disorders can cause significant muscle weakness, fatigue, and other symptoms, which can limit an individual's ability to engage in daily activities. In addition, MM can have a significant emotional and psychological impact on individuals and their families. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorder - **Date:** 1988 (first mitochondrial DNA mutation identified) - **Location:** Worldwide - **Known For:** Impaired energy production and cellular damage due to mitochondrial DNA mutations **TAGS:** Mitochondrial Myopathies, mitochondrial DNA mutations, energy production, cellular damage, muscle weakness, fatigue, exercise intolerance, neurological problems, genetic disorders, rare diseases.